Información del artículo
Resumen
La hemorragia masiva es una entidad frecuente que se asocia a una elevada morbimortalidad. Ante la necesidad de la implementación y estandarización de su manejo, se realizó una revisión sistemática de la literatura, con extracción de recomendaciones en base a las evidencias existentes. A partir de las mismas se redactó un documento de consenso multidisciplinar. Desde las definiciones de hemorragia masiva y transfusión masiva, se establecen recomendaciones de actuación estructuradas en las medidas generales de manejo de las mismas (valoración clínica de la hemorragia, manejo de la hipotermia, reposición de la volemia, reanimación hipotensiva y cirugía de contención de daños), monitorización de la volemia, administración de hemocomponentes (concentrado de hematíes, plasma fresco, plaquetas, y óptima relación de administración entre ellos), y de hemostáticos (complejo protrombínico, fibrinógeno, factor VIIa, antifibrinolíticos).
Palabras clave:
Consenso
Conferencia de consenso
Hemorragia
Choque hemorrágico
Transfusión sanguínea
Transfusión de componentes sanguíneos
Plasma
Abstract
Massive haemorrhage is common and often associated with high morbidity and mortality. We perform a systematic review of the literature, with extraction of the recommendations from the existing evidences because of the need for its improvement and the management standardization. From the results we found, we wrote a multidisciplinary consensus document. We begin with the agreement in the definitions of massive haemorrhage and massive transfusion, and we do structured recommendations on their general management (clinical assessment of bleeding, hypothermia management, fluid therapy, hypotensive resuscitation and damage control surgery), blood volume monitoring, blood products transfusion (red blood cells, fresh frozen plasma, platelets and their best transfusion ratio), and administration of hemostatic components (prothrombin complex, fibrinogen, factor VIIa, antifibrinolytic agents).
Keywords:
Consensus
Consensus development conference
Hemorrhage
Shock, Hemorrhagic
Blood transfusion
Blood component transfusion
Plasma
Artículo
Opciones para acceder a los textos completos de la publicación Revista Española de Anestesiología y Reanimación
Suscriptor
Comprar
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
G.H. Guyatt, A.D. Oxman, R. Kunz, G.E. Vist, Y. Falck-Ytter, H.J. Schunemann, et al.
What is quality of evidence and why is it important to clinicians?.
BMJ, 336 (2008), pp. 995-998
[2]
G.H. Guyatt, A.D. Oxman, R. Kunz, Y. Falck-Ytter, G.E. Vist, A. Liberati, et al.
Going from evidence to recommendations.
BMJ., 336 (2008), pp. 1049-1051
[3]
D. Stainsby, S. MacLennan, P.J. Hamilton.
Management of massive blood loss: A template guideline.
Br J Anaesth., 85 (2000), pp. 487-491
[4]
J.F. Hardy, P. de Moerloose, C.M. Samama, Members of the Groupe d’Interet en Hemostase P.
Massive transfusion and coagulopathy: Pathophysiology and implications for clinical management.
Can J Anaesth., 53 (2006), pp. S40-S58
[5]
M.A. Hayter, K. Pavenski, J. Baker.
Massive transfusion in the trauma patient: Continuing professional development.
Can J Anaesth., 59 (2012), pp. 1130-1145
[6]
National Blood Authority (NBA).
Patient Blood Management Guidelines: Module 1 — Critical Bleeding/Massive Transfusion.
NBA, (2011),
[7]
D.L. Malone, J.R. Hess, A. Fingerhut.
Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol.
J Trauma., 60 (2006), pp. S91-S96
[8]
K.C. Sihler, L.M. Napolitano.
Massive transfusion: New insights.
Chest., 136 (2009), pp. 1654-1667
[9]
T.C. Nunez, I.V. Voskresensky, L.A. Dossett, R. Shinall, W.D. Dutton, B.A. Cotton.
Early prediction of massive transfusion in trauma: Simple as ABC (assessment of blood consumption)?.
J Trauma., 66 (2009), pp. 346-352
[10]
T.H. Rainer, A.M. Ho, J.H. Yeung, N.K. Cheung, R.S. Wong, N. Tang, et al.
Early risk stratification of patients with major trauma requiring massive blood transfusion.
Resuscitation., 82 (2011), pp. 724-729
[11]
M.A. Schreiber, J. Perkins, L. Kiraly, S. Underwood, C. Wade, J.B. Holcomb.
Early predictors of massive transfusion in combat casualties.
J Am Coll Surg., 205 (2007), pp. 541-545
[12]
M.J. Vandromme, R.L. Griffin, G. McGwin Jr., J.A. Weinberg, L.W. Rue 3rd, J.D. Kerby.
Prospective identification of patients at risk for massive transfusion: An imprecise endeavour.
Am Surg., 77 (2011), pp. 155-161
[13]
N. Yucel, R. Lefering, M. Maegele, M. Vorweg, T. Tjardes, S. Ruchholtz, et al.
Trauma Associated Severe Hemorrhage (TASH)-Score: Probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma.
J Trauma., 60 (2006), pp. 36-37
[14]
T. Brockamp, U. Nienaber, M. Mutschler, A. Wafaisade, S. Peiniger, R. Lefering, et al.
Predicting on-going hemorrhage and transfusion requirement after severe trauma: A validation of six scoring systems and algorithms on the TraumaRegister DGU(R).
Crit Care., 16 (2012), pp. R129
[15]
B. Mitra, T.H. Rainer, P.A. Cameron.
Predicting massive blood transfusion using clinical scores post-trauma.
Vox Sang., 102 (2012), pp. 324-330
[16]
M. Maegele, R. Lefering, A. Wafaisade, P. Theodorou, S. Wutzler, P. Fischer, et al.
Revalidation and update of the TASH-Score: A scoring system to predict the probability for massive transfusion as a surrogate for life-threatening haemorrhage after severe injury.
Vox Sang., 100 (2011), pp. 231-238
[17]
S.M. Cinelli, P. Brady, C.P. Rennie, C. Tuluca, T.S. Hall.
Comparative results of trauma scoring systems in fatal outcomes.
Conn Med., 73 (2009), pp. 261-265
[18]
A. Narci, O. Solak, N. Turhan-Haktanir, A. Aycicek, Y. Demir, Y. Ela, et al.
The prognostic importance of trauma scoring systems in pediatric patients.
Pediatr Surg Int., 25 (2009), pp. 25-30
[19]
L. Moore, A. Lavoie, A.F. Turgeon, B. Abdous, N. Le Sage, M. Emond, et al.
The trauma risk adjustment model: A new model for evaluating trauma care.
Ann Surg., 249 (2009), pp. 1040-1046
[20]
J. Charbit, M. Mahul, J.P. Roustan, P. Latry, I. Millet, P. Taourel, et al.
Hemoperitoneum semiquantitative analysis on admission of blunt trauma patients improves the prediction of massive transfusion.
Am J Emerg Med., 31 (2013), pp. 130-136
[21]
B.M. Scavone, P. Toledo, N. Higgins, K. Wojciechowski, R.J. McCarthy.
A randomized controlled trial of the impact of simulation-based training on resident performance during a simulated obstetric anesthesia emergency.
Simul Healthc., 5 (2010), pp. 320-324
[22]
Soporte Vital Avanzado en Trauma (ATLS).
Manual del Curso para Estudiantes.
9.a ed, American College of Surgeons, (2012),
[23]
S. Burman, B.A. Cotton.
Trauma patients at risk for massive transfusion: The role of scoring systems and the impact of early identification on patient outcomes.
Expert Rev Hematol., 5 (2012), pp. 211-218
[24]
B.A. Cotton, L.A. Dossett, E.R. Haut, S. Shafi, T.C. Nunez, B.K. Au, et al.
Multicenter validation of a simplified score to predict massive transfusion in trauma.
J Trauma., 69 (2010), pp. S33-S39
[25]
T.C. Nunez, W.D. Dutton, A.K. May, J.B. Holcomb, P.P. Young, B.A. Cotton.
Emergency department blood transfusion predicts early massive transfusion and early blood component requirement.
Transfusion., 50 (2010), pp. 1914-1920
[26]
R. Davenport, J. Manson, H. De’Ath, S. Platton, A. Coates, S. Allard, et al.
Functional definition and characterization of acute traumatic coagulopathy.
Crit Care Med., 39 (2011), pp. 2652-2658
[27]
H. Schochl, B. Cotton, K. Inaba, U. Nienaber, H. Fischer, W. Voelckel, et al.
FIBTEM provides early prediction of massive transfusion in trauma.
Crit Care., 15 (2011), pp. R265
[28]
B.A. Cotton, G. Faz, Q.M. Hatch, Z.A. Radwan, J. Podbielski, C. Wade, et al.
Rapid thrombelastography delivers real-time results that predict transfusion within 1hour of admission.
J Trauma., 71 (2011), pp. 407-414
[29]
B.A. Cotton, L.A. Dossett, B.K. Au, T.C. Nunez, A.M. Robertson, P.P. Young.
Room for (performance) improvement: Provider-related factors associated with poor outcomes in massive transfusion.
J Trauma., 67 (2009), pp. 1004-1012
[30]
B.A. Cotton, O.L. Gunter, J. Isbell, B.K. Au, A.M. Robertson, J.A. Morris Jr., et al.
Damage control hematology: The impact of a trauma exsanguination protocol on survival and blood product utilization.
J Trauma., 64 (2008), pp. 1177-1182
[31]
T. O’Keeffe, M. Refaai, K. Tchorz, J.E. Forestner, R. Sarode.
A massive transfusion protocol to decrease blood component use and costs.
Arch Surg., 143 (2008), pp. 686-690
[32]
M.A. Borgman, P.C. Spinella, J.B. Holcomb, L.H. Blackbourne, C.E. Wade, R. Lefering, et al.
The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score.
Vox Sang., 101 (2011), pp. 44-54
[33]
D.J. Riskin, T.C. Tsai, L. Riskin, T. Hernandez-Boussard, M. Purtill, P.M. Maggio, et al.
Massive transfusion protocols: The role of aggressive resuscitation versus product ratio in mortality reduction.
J Am Coll Surg., 209 (2009), pp. 198-205
[34]
C.J. Dente, B.H. Shaz, J.M. Nicholas, R.S. Harris, A.D. Wyrzykowski, S. Patel, et al.
Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center.
J Trauma., 66 (2009), pp. 1616-1624
[35]
D.B. Hoyt, R.P. Dutton, C.J. Hauser, J.R. Hess, J.B. Holcomb, Y. Kluger, et al.
Management of coagulopathy in the patients with multiple injuries: Results from an international survey of clinical practice.
J Trauma., 65 (2008), pp. 755-764
[36]
T.C. Nunez, P.P. Young, J.B. Holcomb, B.A. Cotton.
Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient.
J Trauma., 68 (2010), pp. 1498-1505
[37]
J.C. Enticott, S. Jeffcott, J.E. Ibrahim, E.M. Wood, M. Cole-Sinclair, M. Fitzgerald, et al.
A review on decision support for massive transfusion: Understanding human factors to support the implementation of complex interventions in trauma.
Transfusion., 52 (2012), pp. 2692-2705
[38]
A.J. Wikkelsoe, A. Afshari, J. Wetterslev, J. Brok, A.M. Moeller.
Monitoring patients at risk of massive transfusion with thrombelastography or thromboelastometry: A systematic review.
Acta Anaesthesiol Scand., 55 (2011), pp. 1174-1189
[39]
H.R. Champion, W.J. Sacco, A.J. Carnazzo, W. Copes, W.J. Fouty.
Trauma score.
Crit Care Med., 9 (1981), pp. 672-676
[40]
H.R. Champion, W.J. Sacco, W.S. Copes, D.S. Gann, T.A. Gennarelli, M.E. Flanagan.
A revision of the Trauma Score.
J Trauma., 29 (1989), pp. 623-629
[41]
D.R. Spahn, B. Bouillon, V. Cerny, T.J. Coats, J. Duranteau, E. Fernandez-Mondejar, et al.
Management of bleeding and coagulopathy following major trauma: An updated European guideline.
Crit Care., 17 (2013), pp. R76
[42]
S.R. Bruijns, H.R. Guly, O. Bouamra, F. Lecky, L.A. Wallis.
The value of the difference between ED and prehospital vital signs in predicting outcome in trauma.
Emerg Med J., 31 (2014), pp. 579-582
[43]
M. Mutschler, U. Nienaber, T. Brockamp, A. Wafaisade, T. Fabian, T. Paffrath, et al.
Renaissance of base deficit for the initial assessment of trauma patients: A base deficit-based classification for hypovolemic shock developed on data from 16,305 patients derived from the TraumaRegister DGU(R).
Crit Care., 17 (2013), pp. R42
[44]
L. Paladino, R. Sinert, D. Wallace, T. Anderson, K. Yadav, S. Zehtabchi.
The utility of base deficit and arterial lactate in differentiating major from minor injury in trauma patients with normal vital signs.
Resuscitation., 77 (2008), pp. 363-368
[45]
M. Wilson, D.P. Davis, R. Coimbra.
Diagnosis and monitoring of hemorrhagic shock during the initial resuscitation of multiple trauma patients: A review.
J Emerg Med., 24 (2003), pp. 413-422
[46]
B.L. Zarzaur, M.A. Croce, P.E. Fischer, L.J. Magnotti, T.C. Fabian.
New vitals after injury: Shock index for the young and age x shock index for the old.
J Surg Res., 147 (2008), pp. 229-236
[47]
S.R. Bruijns, H.R. Guly, O. Bouamra, F. Lecky, W.A. Lee.
The value of traditional vital signs, shock index, and age-based markers in predicting trauma mortality.
J Trauma Acute Care Surg., 74 (2013), pp. 1432-1437
[48]
J.W. Davis, K.L. Kaups, S.N. Parks.
Base deficit is superior to pH in evaluating clearance of acidosis after traumatic shock.
J Trauma., 44 (1998), pp. 114-118
[49]
J.B. Kortbeek, S.A. Al Turki, J. Ali, J.A. Antoine, B. Bouillon, K. Brasel, et al.
Advanced trauma life support, 8th edition, the evidence for change.
J Trauma., 64 (2008), pp. 1638-1650
[50]
E.E. Moore, G. Thomas.
Orr Memorial Lecture. Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome.
Am J Surg., 172 (1996), pp. 405-410
[51]
M. Mutschler, U. Nienaber, T. Brockamp, A. Wafaisade, H. Wyen, S. Peiniger, et al.
A critical reappraisal of the ATLS classification of hypovolaemic shock: Does it really reflect clinical reality?.
Resuscitation, 84 (2013), pp. 309-313
[52]
K.C. Sihler, L.M. Napolitano.
Complications of massive transfusion.
Chest., 137 (2010), pp. 209-220
[53]
B.A. McKinley, E.A. Gonzalez, B.C. Balldin, T.H. Mahid, A. Valdivia, C.S. Kokanour, et al.
Revisiting the “Bloody Vicious Cycle”.
Shock, 21 (2004), pp. 47
[54]
M. Maegele, H. Schochl, M.J. Cohen.
An update on the coagulopathy of trauma.
Shock., 41 (2014), pp. 21-25
[55]
H.E. Wang, C.W. Callaway, A.B. Peitzman, S.A. Tisherman.
Admission hypothermia and outcome after major trauma.
Crit Care Med., 33 (2005), pp. 1296-1301
[56]
G.J. Jurkovich, W.B. Greiser, A. Luterman, P.W. Curreri.
Hypothermia in trauma victims: An ominous predictor of survival.
J Trauma., 27 (1987), pp. 1019-1024
[57]
L. Uhl, D. Pacini, M.S. Kruskall.
A comparative study of blood warmer performance.
Anesthesiology., 77 (1992), pp. 1022-1028
[58]
L.M. Gentilello, G.J. Jurkovich, M.S. Stark, S.A. Hassantash, G.E. O’Keefe.
Is hypothermia in the victim of major trauma protective or harmful? A randomized, prospective study.
Ann Surg., 226 (1997), pp. 439-447
[59]
D.D. Watts, A. Trask, K. Soeken, P. Perdue, S. Dols, C. Kaufmann.
Hypothermic coagulopathy in trauma: Effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity.
J Trauma., 44 (1998), pp. 846-854
[60]
C.R. Valeri, H. MacGregor, G. Cassidy, R. Tinney, F. Pompei.
Effects of temperature on bleeding time and clotting time in normal male and female volunteers.
Crit Care Med., 23 (1995), pp. 698-704
[61]
A.S. Wolberg, Z.H. Meng, D.M. Monroe, M3rd. Hoffman.
A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function.
J Trauma., 56 (2004), pp. 1221-1228
[62]
H. Schmied, A. Kurz, D.I. Sessler, S. Kozek, A. Reiter.
Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty.
Lancet., 347 (1996), pp. 289-292
[63]
B.R. Reynolds, R.M. Forsythe, B.G. Harbrecht, J. Cuschieri, J.P. Minei, R.V. Maier, et al.
Hypothermia in massive transfusion: Have we been paying enough attention to it?.
J Trauma Acute Care Surg, 73 (2012), pp. 486-491
[64]
H. Lier, H. Krep, S. Schroeder, F. Stuber.
Preconditions of hemostasis in trauma: A review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma.
J Trauma., 65 (2008), pp. 951-960
[65]
M.C. Kelleher, D.J. Buggy.
Pendulum swings again: Crystalloid or colloid fluid therapy?.
Br J Anaesth., 113 (2014), pp. 335-337
[66]
N. Spoerke, J. Michalek, M. Schreiber, G. Trauma Outcomes, K.J. Brasel, G. Vercruysse, et al.
Crystalloid resuscitation improves survival in trauma patients receiving low ratios of fresh frozen plasma to packed red blood cells.
J Trauma., 71 (2011), pp. S380-S383
[67]
S.R. Leal-Noval, M. Munoz, M. Asuero, E. Contreras, J.A. Garcia-Erce, J.V. Llau, et al.
The 2013 Seville Consensus Document on alternatives to allogenic blood transfusion. An update on the Seville Document.
Rev Esp Anestesiol Reanim., 60 (2013), pp. e1-e25
[68]
J.A. Myburgh, M.G. Mythen.
Resuscitation fluids.
N Engl J Med., 369 (2013), pp. 1243-1251
[69]
S. Padhi, I. Bullock, L. Li, M. Stroud.
National Institute for H. Care Excellence Guideline Development G. Intravenous fluid therapy for adults in hospital: Summary of NICE guidance.
BMJ., 347 (2013), pp. f7073
[70]
L. Ketchum, J.R. Hess, S. Hiippala.
Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma.
J Trauma., 60 (2006), pp. S51-S58
[71]
J.B.H.J. Holcomb.
Early massive trauma transfusion: State of the art: Editors’ introduction.
J Trauma., 60 (2006), pp. S1-S2
[72]
C.A. Morrison, M.M. Carrick, M.A. Norman, B.G. Scott, F.J. Welsh, P. Tsai, et al.
Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: Preliminary results of a randomized controlled trial.
J Trauma., 70 (2011), pp. 652-663
[73]
W.H. Bickell, M.J. Wall Jr., P.E. Pepe, R.R. Martin, V.F. Ginger, M.K. Allen, et al.
Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries.
N Engl J Med., 331 (1994), pp. 1105-1109
[74]
M.C. Madigan, C.D. Kemp, J.C. Johnson, B.A. Cotton.
Secondary abdominal compartment syndrome after severe extremity injury: Are early, aggressive fluid resuscitation strategies to blame?.
J Trauma, 64 (2008), pp. 280-285
[75]
E.R. Haut, B.T. Kalish, B.A. Cotton, D.T. Efron, A.H. Haider, K.A. Stevens, et al.
Prehospital intravenous fluid administration is associated with higher mortality in trauma patients: A National Trauma Data Bank analysis.
Ann Surg., 253 (2011), pp. 371-377
[76]
E.J. Ley, M.A. Clond, M.K. Srour, M. Barnajian, J. Mirocha, D.R. Margulies, et al.
Emergency department crystalloid resuscitation of 1.5 L or more is associated with increased mortality in elderly and nonelderly trauma patients.
J Trauma., 70 (2011), pp. 398-400
[77]
C. Berry, E.J. Ley, M. Bukur, D. Malinoski, D.R. Margulies, J. Mirocha, et al.
Redefining hypotension in traumatic brain injury.
Injury., 43 (2012), pp. 1833-1837
[78]
M. Brenner, D.M. Stein, P.F. Hu, B. Aarabi, K. Sheth, T.M. Scalea.
Traditional systolic blood pressure targets underestimate hypotension-induced secondary brain injury.
J Trauma Acute Care Surg., 72 (2012), pp. 1135-1139
[79]
J.L. Sperry, J.P. Minei, H.L. Frankel, M.A. West, B.G. Harbrecht, E.E. Moore, et al.
Early use of vasopressors after injury: Caution before constriction.
J Trauma., 64 (2008), pp. 9-14
[80]
R. Cirocchi, I. Abraha, A. Montedori, E. Farinella, I. Bonacini, L. Tagliabue, et al.
Damage control surgery for abdominal trauma.
Cochrane Database Syst Rev., 1 (2010), pp. CD007438
[81]
J.C. Duchesne, K. Kimonis, A.B. Marr, K.V. Rennie, G. Wahl, J.E. Wells, et al.
Damage control resuscitation in combination with damage control laparotomy: A survival advantage.
J Trauma., 69 (2010), pp. 46-52
[82]
C.A. Ordonez, M. Badiel, L.F. Pino, J.C. Salamea, J.H. Loaiza, M.W. Parra, et al.
Damage control resuscitation: Early decision strategies in abdominal gunshot wounds using an easy ABCD mnemonic.
J Trauma Acute Care Surg., 73 (2012), pp. 1074-1078
[83]
B.A. Cotton, N. Reddy, Q.M. Hatch, E. LeFebvre, C.E. Wade, R.A. Kozar, et al.
Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients.
Ann Surg., 254 (2011), pp. 598-605
[84]
R.C. Skeate, T. Eastlund.
Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload.
Curr Opin Hematol., 14 (2007), pp. 682-687
[85]
P.E. Marik, M. Baram, B. Vahid.
Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares.
Chest., 134 (2008), pp. 172-178
[86]
P.E. Marik, R. Cavallazzi.
Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense.
Crit Care Med., 41 (2013), pp. 1774-1781
[87]
F. Michard, J.L. Teboul.
Predicting fluid responsiveness in ICU patients: A critical analysis of the evidence.
Chest., 121 (2002), pp. 2000-2008
[88]
M. Cecconi, A.K. Parsons, A. Rhodes.
What is a fluid challenge?.
Curr Opin Crit Care, 17 (2011), pp. 290-295
[89]
B. Vallet, Y. Blanloeil, B. Cholley, G. Orliaguet, S. Pierre, B. Tavernier.
Guidelines for perioperative haemodynamic optimization.
Ann Fr Anesth Reanim., 32 (2013), pp. e151-e158
[90]
M. Cecconi, D. de Backer, M. Antonelli, R. Beale, J. Bakker, C. Hofer, et al.
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.
Intensive Care Med., 40 (2014), pp. 1795-1815
[91]
Z. Zhang, B. Lu, X. Sheng, N. Jin.
Accuracy of stroke volume variation in predicting fluid responsiveness: A systematic review and meta-analysis.
J Anesth., 25 (2011), pp. 904-916
[92]
T.G. Cherpanath, B.F. Geerts, W.K. Lagrand, M.J. Schultz, A.B. Groeneveld.
Basic concepts of fluid responsiveness.
Neth Heart J., 21 (2013), pp. 530-536
[93]
S.A. Kozek-Langenecker, A. Afshari, P. Albaladejo, C.A. Santullano, E. De Robertis, D.C. Filipescu, et al.
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology.
Eur J Anaesthesiol., 30 (2013), pp. 270-382
[94]
M.S. Chew, A. Aneman.
Haemodynamic monitoring using arterial waveform analysis.
Curr Opin Crit Care., 19 (2013), pp. 234-241
[95]
P.E. Marik, R. Cavallazzi, T. Vasu, A. Hirani.
Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: A systematic review of the literature.
Crit Care Med., 37 (2009), pp. 2642-2647
[96]
R.J. Luddington.
Thrombelastography/thromboelastometry.
Clin Lab Haematol., 27 (2005), pp. 81-90
[97]
P.I. Johansson.
Coagulation monitoring of the bleeding traumatized patient.
Curr Opin Anaesthesiol., 25 (2012), pp. 235-241
[98]
K. Brohi, J. Singh, M. Heron, T. Coats.
Acute traumatic coagulopathy.
J Trauma., 54 (2003), pp. 1127-1130
[99]
H. Schochl, U. Nienaber, G. Hofer, W. Voelckel, C. Jambor, G. Scharbert, et al.
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.
Crit Care., 14 (2010), pp. R55
[100]
J.L. Kashuk, E.E. Moore, M. Sawyer, T. Le, J. Johnson, W.L. Biffl, et al.
Postinjury coagulopathy management: Goal directed resuscitation via POC thrombelastography.
Ann Surg., 251 (2010), pp. 604-614
[101]
W.C. Wu, S.S. Rathore, Y. Wang, M.J. Radford, H.M. Krumholz.
Blood transfusion in elderly patients with acute myocardial infarction.
N Engl J Med., 345 (2001), pp. 1230-1236
[102]
D.R. Gerber.
Transfusion of packed red blood cells in patients with ischemic heart disease.
Crit Care Med., 36 (2008), pp. 1068-1074
[103]
L.A. Hajjar, J.L. Vincent, F.R. Galas, R.E. Nakamura, C.M. Silva, M.H. Santos, et al.
Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial.
JAMA., 304 (2010), pp. 1559-1567
[104]
C. Villanueva, A. Colomo, A. Bosch, M. Concepcion, V. Hernandez-Gea, C. Aracil, et al.
Transfusion strategies for acute upper gastrointestinal bleeding.
N Engl J Med., 368 (2013), pp. 11-21
[105]
J.L. Callum, S. Rizoli.
Assessment and management of massive bleeding: Coagulation assessment, pharmacologic strategies, and transfusion management.
Hematology Am Soc Hematol Educ Program., 2012 (2012), pp. 522-528
[106]
M.A. Borgman, P.C. Spinella, J.G. Perkins, K.W. Grathwohl, T. Repine, A.C. Beekley, et al.
The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital.
J Trauma., 63 (2007), pp. 805-813
[107]
P.C. Spinella, J.G. Perkins, K.W. Grathwohl, A.C. Beekley, S.E. Niles, D.F. McLaughlin, et al.
Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries.
J Trauma., 64 (2008), pp. S69-S77
[108]
J.W. Simmons, C.E. White, B.J. Eastridge, J.E. Mace, C.E. Wade, L.H. Blackbourne.
Impact of policy change on US Army combat transfusion practices.
J Trauma., 69 (2010), pp. S75-S80
[109]
T. Hannon.
Trauma blood management: Avoiding the collateral damage of trauma resuscitation protocols.
Hematology Am Soc Hematol Educ Program., 2010 (2010), pp. 463-464
[110]
J.L. Johnson, E.E. Moore, J.L. Kashuk, A. Banerjee, C.C. Cothren, W.L. Biffl, et al.
Effect of blood products transfusion on the development of postinjury multiple organ failure.
Arch Surg., 145 (2010), pp. 973-977
[111]
C.N. Sambasivan, N.R. Kunio, P.V. Nair, K.A. Zink, J.E. Michalek, J.B. Holcomb, et al.
High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients.
J Trauma., 71 (2011), pp. S329-S336
[112]
K. Inaba, B.C. Branco, P. Rhee, L.H. Blackbourne, J.B. Holcomb, P.G. Teixeira, et al.
Impact of plasma transfusion in trauma patients who do not require massive transfusion.
J Am Coll Surg., 210 (2010), pp. 957-965
[113]
B. Nascimento, J. Callum, H. Tien, G. Rubenfeld, R. Pinto, Y. Lin, et al.
Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: A randomized feasibility trial.
CMAJ., 185 (2013), pp. E583-E589
[114]
D. Fries.
The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
Transfusion, 53 (2013), pp. 91S-95S
[115]
P.I. Johansson, J. Stensballe, I. Rosenberg, T.L. Hilslov, L. Jorgensen, N.H. Secher.
Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: Evaluating a change in transfusion practice.
Transfusion., 47 (2007), pp. 593-598
[116]
S.J. Stanworth.
The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.
Hematology Am Soc Hematol Educ Program., 17 (2007), pp. 9-86
[117]
P. Chowdary, A.G. Saayman, U. Paulus, G.P. Findlay, P.W. Collins.
Efficacy of standard dose and 30ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.
Br J Haematol., 125 (2004), pp. 69-73
[118]
D. Thomas, M. Wee, P. Clyburn, I. Walker, K. Brohi, P. Collins, Association of Anaesthetists of Great Britain and Ireland, et al.
Blood transfusion and the anaesthetist: management of massive haemorrhage.
Anaesthesia, 65 (2010), pp. 1153-1161
[119]
British Committee for Standards in Haematology BTTF.
Guidelines for the use of platelet transfusions.
Br J Haematol., 122 (2003), pp. 10-23
[120]
M. Lozano, J. Cid.
Consensus and controversies in platelet transfusion: Trigger for indication, and platelet dose.
Transfus Clin Biol., 14 (2007), pp. 504-508
[121]
D. Stainsby, S. MacLennan, D. Thomas, J. Isaac, P.J. Hamilton, British Committee for Standards in Haematology.
Guidelines on the management of massive blood loss.
Br J Haematol., 135 (2006), pp. 634-641
[122]
G. Liumbruno, F. Bennardello, A. Lattanzio, P. Piccoli, G. Rossetti, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party.
Recommendations for the transfusion of plasma and platelets.
Blood Transfus., 7 (2009), pp. 132-150
[123]
D.F. O'Shaughnessy, C. Atterbury, P. Bolton Maggs, M. Murphy, D. Thomas, S. Yates, et al.
Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.
Br J Haematol., 126 (2004), pp. 11-28
[124]
B. Schnuriger, K. Inaba, G.A. Abdelsayed, T. Lustenberger, B.M. Eberle, G. Barmparas, et al.
The impact of platelets on the progression of traumatic intracranial hemorrhage.
J Trauma., 68 (2010), pp. 881-885
[125]
T. Thiele, N. Heddle, A. Greinacher.
Donor exposures in recipients of pooled platelet concentrates.
N Engl J Med., 368 (2013), pp. 487-489
[126]
L.J. Dumont, Z.M. Szczepiorkowski.
Pooled platelet concentrates or apheresis platelets?.
N Engl J Med, 368 (2013), pp. 1848-1849
[127]
P.A. Carless, F.D. Rubens, D.M. Anthony, D. O’Connell, D.A. Henry.
Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion.
Cochrane Database Syst Rev., (2011),
[128]
D.J. Triulzi, S.F. Assmann, R.G. Strauss, P.M. Ness, J.R. Hess, R.M. Kaufman, et al.
The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia.
Blood., 119 (2012), pp. 5553-5562
[129]
C. Butler, C. Doree, L.J. Estcourt, M. Trivella, S. Hopewell, S.J. Brunskill, et al.
Pathogen-reduced platelets for the prevention of bleeding.
Cochrane Database Syst Rev., 3 (2013), pp. CD009072
[130]
H.R. Schlossberg, J.H. Herman.
Platelet dosing.
Transfus Apher Sci., 28 (2003), pp. 221-226
[131]
G. Escolar, M. Garrido, R. Mazzara, R. Castillo, A. Ordinas.
Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients.
Transfusion., 28 (1988), pp. 406-411
[132]
C.H. Ho.
The hemostatic effect of adequate red cell transfusion in patients with anemia and thrombocytopenia.
Transfusion., 36 (1996), pp. 290
[133]
C.R. Valeri, G. Cassidy, L.E. Pivacek, G. Ragno, W. Lieberthal, J.P. Crowley, et al.
Anemia-induced increase in the bleeding time: Implications for treatment of nonsurgical blood loss.
Transfusion., 41 (2001), pp. 977-983
[134]
M. Eugster, W.H. Reinhart.
The influence of the haematocrit on primary haemostasis in vitro.
Thromb Haemost., 94 (2005), pp. 1213-1218
[135]
J. Seghatchian, M.M. Samama.
Massive transfusion: An overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy.
Transfus Apher Sci., 47 (2012), pp. 235-243
[136]
Y. Lin, C.L. Saw, B. Hannach, M. Goldman.
Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
Transfusion., 52 (2012), pp. 567-574
[137]
The SAFE Study Investigators.
Saline or albumin for fluid resuscitation in patients with traumatic brain injury.
N Engl J Med, 357 (2007), pp. 874-884
[138]
J.L. Vincent, Y. Sakr, K. Reinhart, C.L. Sprung, H. Gerlach, V.M. Ranieri, et al.
Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study.
Crit Care., 9 (2005), pp. R745-R754
[139]
P. Alderson, F. Bunn, C. Lefebvre, W.P. Li, L. Li, I. Roberts, et al.
Human albumin solution for resuscitation and volume expansion in critically ill patients.
Cochrane Database Syst Rev., (2004),
[140]
J. Barnard, R. Millner.
A review of topical hemostatic agents for use in cardiac surgery.
Ann Thorac Surg., 88 (2009), pp. 1377-1383
[142]
R. Sarode, T.J. Milling Jr., M.A. Refaai, A. Mangione, A. Schneider, B.L. Durn, et al.
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
Circulation., 128 (2013), pp. 1234-1243
[143]
A.E. Patanwala, N.M. Acquisto, B.L. Erstad.
Prothrombin complex concentrate for critical bleeding.
Ann Pharmacother., 45 (2011), pp. 990-999
[144]
J. Ferreira, M. DeLosSantos.
The clinical use of prothrombin complex concentrate.
J Emerg Med., 44 (2013), pp. 1201-1210
[145]
W.S. Stewart, H. Pettit.
Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
Am J Emerg Med., 31 (2013), pp. 1251-1254
[146]
G.M. Rodgers.
Prothrombin complex concentrates in emergency bleeding disorders.
Am J Hematol., 87 (2012), pp. 898-902
[147]
D.J. Quinlan, J.W. Eikelboom, J.I. Weitz.
Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
Circulation., 128 (2013), pp. 1179-1181
[148]
J.A. Switzer, J. Rocker, P. Mohorn, J.L. Waller, D. Hughes, A. Bruno, et al.
Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage.
Stroke., 43 (2012), pp. 2500-2502
[149]
M. Franchini, G. Lippi.
Prothrombin complex concentrates: An update.
Blood Transfus., 8 (2010), pp. 149-154
[150]
S.T. Hiippala, G.J. Myllyla, E.M. Vahtera.
Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates.
Anesth Analg., 81 (1995), pp. 360-365
[151]
J.F. Hardy, P. De Moerloose, M. Samama, Groupe d’intérêt en Hémostase Périopératoire.
Massive transfusion and coagulopathy: Pathophysiology and implications for clinical management.
Can J Anaesth., 51 (2004), pp. 293-310
[152]
B. Charbit, L. Mandelbrot, E. Samain, G. Baron, B. Haddaoui, H. Keita, et al.
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage.
J Thromb Haemost., 5 (2007), pp. 266-273
[153]
I.J. Mackie, S. Kitchen, S.J. Machin, G.D. Lowe, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
Guidelines on fibrinogen assays.
Br J Haematol., 121 (2003), pp. 396-404
[154]
E. Schaden, D. Hoerburger, S. Hacker, P. Kraincuk, D.M. Baron, S. Kozek-Langenecker.
Fibrinogen function after severe burn injury.
Burns., 38 (2012), pp. 77-82
[155]
T. Haas, N. Spielmann, J. Mauch, C. Madjdpour, O. Speer, M. Schmugge, et al.
Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery.
Br J Anaesth., 108 (2012), pp. 36-41
[156]
S. Ogawa, F. Szlam, E.P. Chen, T. Nishimura, H. Kim, J.D. Roback, et al.
A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery.
Transfusion., 52 (2012), pp. 14-22
[157]
M. Blome, F. Isgro, A.H. Kiessling, J. Skuras, H. Haubelt, P. Hellstern, et al.
Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery.
Thromb Haemost., 93 (2005), pp. 1101-1107
[158]
D. Bolliger, F. Szlam, R.J. Molinaro, N. Rahe-Meyer, J.H. Levy, K.A. Tanaka.
Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model.
Br J Anaesth., 102 (2009), pp. 793-799
[159]
A. Wikkelso, J. Lunde, M. Johansen, J. Stensballe, J. Wetterslev, A.M. Moller, et al.
Fibrinogen concentrate in bleeding patients.
Cochrane Database Syst Rev., 8 (2013), pp. CD008864
[160]
O.M. Theusinger, C.M. Schroder, J. Eismon, M.Y. Emmert, B. Seifert, D.R. Spahn, et al.
The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
Anesth Analg., 117 (2013), pp. 314-321
[161]
L. Rugeri, A. Levrat, J.S. David, E. Delecroix, B. Floccard, A. Gros, et al.
Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography.
J Thromb Haemost., 5 (2007), pp. 289-295
[162]
T. Haas, D. Fries, C. Velik-Salchner, E. Oswald, P. Innerhofer.
Fibrinogen in craniosynostosis surgery.
Anesth Analg., 106 (2008), pp. 725-731
[163]
T. Lang, A. Bauters, S.L. Braun, B. Potzsch, K.W. von Pape, H.J. Kolde, et al.
Multi-centre investigation on reference ranges for ROTEM thromboelastometry.
Blood Coagul Fibrinolysis., 16 (2005), pp. 301-310
[164]
J.N. Harr, E.E. Moore, A. Ghasabyan, T.L. Chin, A. Sauaia, A. Banerjee, et al.
Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.
Shock., 39 (2013), pp. 45-49
[165]
C. Fenger-Eriksen, T.M. Jensen, B.S. Kristensen, K.M. Jensen, E. Tonnesen, J. Ingerslev, et al.
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial.
J Thromb Haemost., 7 (2009), pp. 795-802
[166]
K. Gorlinger, D. Dirkmann, C. Solomon, A.A. Hanke.
Fast interpretation of thromboelastometry in non-cardiac surgery: Reliability in patients with hypo-, normo-, and hypercoagulability.
Br J Anaesth., 110 (2013), pp. 222-230
[167]
J.G. Song, S.M. Jeong, I.G. Jun, H.M. Lee, G.S. Hwang.
Five-minute parameter of thromboelastometry is sufficient to detect thrombocytopenia and hypofibrinogenaemia in patients undergoing liver transplantation.
Br J Anaesth., 112 (2014), pp. 290-297
[168]
J.H. Levy, F. Szlam, K.A. Tanaka, R.M. Sniecienski.
Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding.
Anesth Analg., 114 (2012), pp. 261-274
[169]
R. Weinkove, S. Rangarajan.
Fibrinogen concentrate for acquired hypofibrinogenaemic states.
Transfus Med., 18 (2008), pp. 151-157
[170]
C. Solomon, U. Pichlmaier, H. Schoechl, C. Hagl, K. Raymondos, D. Scheinichen, et al.
Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.
Br J Anaesth., 104 (2010), pp. 555-562
[171]
K. Gorlinger, D. Fries, D. Dirkmann, C.F. Weber, A.A. Hanke, H. Schochl.
Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy.
Transfus Med Hemother., 39 (2012), pp. 104-113
[172]
P. Innerhofer, I. Westermann, H. Tauber, R. Breitkopf, D. Fries, T. Kastenberger, et al.
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma.
Injury., 44 (2013), pp. 209-216
[173]
H. Schochl, U. Nienaber, M. Maegele, G. Hochleitner, F. Primavesi, B. Steitz, et al.
Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.
Crit Care., 15 (2011), pp. R83
[174]
M. Mittermayr, W. Streif, T. Haas, D. Fries, C. Velik-Salchner, A. Klingler, et al.
Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration.
Anesth Analg., 105 (2007), pp. 905-917
[175]
N. Rahe-Meyer, C. Solomon, A. Hanke, D.S. Schmidt, D. Knoerzer, G. Hochleitner, et al.
Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial.
Anesthesiology., 118 (2013), pp. 40-50
[176]
N. Rahe-Meyer, M. Pichlmaier, A. Haverich, C. Solomon, M. Winterhalter, S. Piepenbrock, et al.
Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: A pilot study.
Br J Anaesth., 102 (2009), pp. 785-792
[177]
N. Rahe-Meyer, C. Solomon, M. Winterhalter, S. Piepenbrock, K. Tanaka, A. Haverich, et al.
Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
J Thorac Cardiovasc Surg., 138 (2009), pp. 694-702
[178]
C. Solomon, H. Schochl, A. Hanke, A. Calatzis, C. Hagl, K. Tanaka, et al.
Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: Comparison of fibrinogen concentrate with allogeneic blood products.
Scand J Clin Lab Invest., 72 (2012), pp. 121-128
[179]
K. Gorlinger, D. Dirkmann, A.A. Hanke, M. Kamler, E. Kottenberg, M. Thielmann, et al.
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study.
Anesthesiology., 115 (2011), pp. 1179-1191
[180]
M. Karlsson, L. Ternstrom, M. Hyllner, F. Baghaei, A. Flinck, S. Skrtic, et al.
Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study.
Thromb Haemost., 102 (2009), pp. 137-144
[181]
A.J. Wikkelso, H.M. Edwards, A. Afshari, J. Stensballe, J. Langhoff-Roos, C. Albrechtsen, et al.
Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trialdagger.
Br J Anaesth., 114 (2015), pp. 623-633
[182]
S. Kozek-Langenecker, B. Sorensen, J.R. Hess, D.R. Spahn.
Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review.
Crit Care., 15 (2011), pp. R239
[183]
M. Warmuth, P. Mad, C. Wild.
Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults.
Acta Anaesthesiol Scand., 56 (2012), pp. 539-548
[184]
C. Solomon, C. Hagl, N. Rahe-Meyer.
Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.
Br J Anaesth., 110 (2013), pp. 947-956
[185]
L. Yang, S. Stanworth, T. Baglin.
Cryoprecipitate: An outmoded treatment?.
Transfus Med., 22 (2012), pp. 315-320
[186]
B.M. Elliott, L.M. Aledort.
Restoring hemostasis: Fibrinogen concentrate versus cryoprecipitate.
Expert Rev Hematol., 6 (2013), pp. 277-286
[187]
B. Sorensen, O.H. Larsen, C.J. Rea, M. Tang, J.H. Foley, C. Fenger-Eriksen.
Fibrinogen as a hemostatic agent.
Semin Thromb Hemost., 38 (2012), pp. 268-273
[188]
J.H. Levy, I. Welsby, L.T. Goodnough.
Fibrinogen as a therapeutic target for bleeding: A review of critical levels and replacement therapy.
Transfusion., 54 (2014), pp. 1389-31405
[189]
B. Sorensen, D. Bevan.
A critical evaluation of cryoprecipitate for replacement of fibrinogen.
Br J Haematol., 149 (2010), pp. 834-843
[190]
M.E. Steiner, N.S. Key, J.H. Levy.
Activated recombinant factor VII in cardiac surgery.
Curr Opin Anaesthesiol., 18 (2005), pp. 89-92
[191]
L. Heuer, D. Blumenberg.
Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets.
Blood Coagul Fibrinolysis., 16 (2005), pp. 287-290
[192]
EMA. Summary of product characteristics [consultado 12 Mar 2014]. Disponible en: http://www.ema.europa.eu
[193]
M.A. Crowther, T.E. Warkentin.
Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents.
J Thromb Haemost, 7 (2009), pp. 107-110
[194]
B.I. Eriksson, D.J. Quinlan, J.I. Weitz.
Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development.
Clin Pharmacokinet., 48 (2009), pp. 1-22
[195]
A. Gruber, S. Carlsson, H.F. Kotze, U. Marzec, T.C. Sarich, S.R. Hanson.
Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates.
Thromb Res., 119 (2007), pp. 121-127
[196]
L.T. Goodnough, D.M. Lublin, L. Zhang, G. Despotis, C. Eby.
Transfusion medicine service policies for recombinant factor VIIa administration.
Transfusion., 44 (2004), pp. 1325-1331
[197]
R.A. Deveras, C.M. Kessler.
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.
Ann Intern Med., 137 (2002), pp. 884-888
[198]
E. Erhardtsen, P. Nony, M. Dechavanne, P. Ffrench, J.P. Boissel, U. Hedner.
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0.
Blood Coagul Fibrinolysis., 9 (1998), pp. 741-748
[199]
D. Keeling, T. Baglin, C. Tait, H. Watson, D. Perry, C. Baglin, et al.
Guidelines on oral anticoagulation with warfarin — fourth edition.
Br J Haematol., 154 (2011), pp. 311-324
[200]
L.B. Morgenstern, J.C.3rd Hemphill, C. Anderson, K. Becker, J.P. Broderick, E.S. Connolly Jr., et al.
Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke., 41 (2010), pp. 2108-2129
[201]
V. Yank, C.V. Tuohy, A.C. Logan, D.M. Bravata, K. Staudenmayer, R. Eisenhut, et al.
Systematic review: Benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Ann Intern Med., 154 (2011), pp. 529-540
[202]
D.M. Siegal, A. Cuker.
Reversal of novel oral anticoagulants in patients with major bleeding.
J Thromb Thrombolysis., 35 (2013), pp. 391-398
[203]
R. Palmason, B. Vidarsson, K. Sigvaldason, J.P. Ingimarsson, T. Gudbjartsson, G.H. Sigurdsson, et al.
Recombinant factor VIIa as last-resort treatment of desperate haemorrhage.
Acta Anaesthesiol Scand., 56 (2012), pp. 636-644
[204]
M.A. Crowther, T.E. Warkentin.
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: Focus on new anticoagulant agents.
Blood., 111 (2008), pp. 4871-4879
[205]
C.C. Hsia, I.H. Chin-Yee, V.C. McAlister.
Use of recombinant activated factor VII in patients without hemophilia: A meta-analysis of randomized control trials.
Ann Surg., 248 (2008), pp. 61-68
[206]
R.K. Narayan, A.I. Maas, L.F. Marshall, F. Servadei, B.E. Skolnick, M.N. Tillinger, et al.
Recombinant factor VIIA in traumatic intracerebral hemorrhage: Results of a dose-escalation clinical trial.
Neurosurgery., 62 (2008), pp. 776-786
[207]
D.A. Henry, P.A. Carless, A.J. Moxey, D. O’Connell, B.J. Stokes, D.A. Fergusson, et al.
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Cochrane Database Syst Rev., (2011),
[208]
B. Hutton, L. Joseph, D. Fergusson, C.D. Mazer, S. Shapiro, A. Tinmouth.
Risks of harms using antifibrinolytics in cardiac surgery: Systematic review and network meta-analysis of randomised and observational studies.
BMJ., 345 (2012), pp. e5798
[209]
H. Shakur, I. Roberts, R. Bautista, J. Caballero, T. Coats, Y. Dewan, CRASH-2 trial collaborators, et al.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial.
Lancet., 376 (2010), pp. 23-32
[210]
I. Roberts, H. Shakur, A. Afolabi, K. Brohi, T. Coats, Y. Dewan, CRASH-2 collaborators, et al.
The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial.
Lancet, 377 (2011), pp. 1096-1101
[211]
J.F. Angle, N.H. Siddiqi, M.J. Wallace, S. Kundu, L. Stokes, J.C. Wojak, et al.
Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee.
J Vasc Interv Radiol., 21 (2010), pp. 1479-1486
[212]
C. Letoublon, I. Morra, Y. Chen, V. Monnin, D. Voirin, C. Arvieux.
Hepatic arterial embolization in the management of blunt hepatic trauma: Indications and complications.
J Trauma., 70 (2011), pp. 1032-1036
[213]
C.C. Burlew, E.E. Moore, W.R. Smith, J.L. Johnson, W.L. Biffl, C.C. Barnett, et al.
Preperitoneal pelvic packing/external fixation with secondary angioembolization: Optimal care for life-threatening hemorrhage from unstable pelvic fractures.
J Am Coll Surg., 212 (2011), pp. 628-635
[214]
P.E. Bize, R. Duran, D.C. Madoff, N. Golliet-Mercier, C. Heim, F. Pilleul, et al.
Embolization for multicompartmental bleeding in patients in hemodynamically unstable condition: Prognostic factors and outcome.
J Vasc Interv Radiol., 23 (2012), pp. 751-760
[215]
A. Coppola, G. di Minno.
Desmopressin in inherited disorders of platelet function.
Haemophilia, 14 (2008), pp. 31-39
[216]
M. Levi, D. Fries, H. Gombotz, P. van der Linden, B. Nascimento, J.L. Callum, et al.
Prevention and treatment of coagulopathy in patients receiving massive transfusions.
Vox Sang., 101 (2011), pp. 154-174
[217]
K.M. Ho, A.D. Leonard.
Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study.
Anaesth Intensive Care., 39 (2011), pp. 46-54
[218]
L.J. Magnotti, E.H. Bradburn, D.L. Webb, S.D. Berry, P.E. Fischer, B.L. Zarzaur, et al.
Admission ionized calcium levels predict the need for multiple transfusions: A prospective study of 591 critically ill trauma patients.
J Trauma., 70 (2011), pp. 391-395
[219]
T.H. Baron, P.S. Kamath, R.D. McBane.
Management of antithrombotic therapy in patients undergoing invasive procedures.
N Engl J Med., 368 (2013), pp. 2113-2124
[220]
R. Ferrandis, J. Castillo, J. de Andres, C. Gomar, A. Gomez-Luque, F. Hidalgo, et al.
The perioperative management of new direct oral anticoagulants: A question without answers.
Thromb Haemost., 110 (2013), pp. 515-522
[221]
G. Pernod, P. Albaladejo, A. Godier, C.M. Samama, S. Susen, Y. Gruel, et al.
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the working group on perioperative haemostasis (GIHP) — March 2013.
Arch Cardiovasc Dis., 106 (2013), pp. 382-393
[222]
K. Gorlinger, D. Dirkmann, A.A. Hanke.
Potential value of transfusion protocols in cardiac surgery.
Curr Opin Anaesthesiol., 26 (2013), pp. 230-243
